NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









PharmaLegacy

PharmaLegacy

Private
ShanghaiHealthcare & Life Scienceshttps://pharmalegacy.com/

Last Round

M&A

Jan 13, 2026

Est. Valuation

$202M

Total Funding Raised

$100M

Company Overview

PharmaLegacy is a life sciences company that operates as a preclinical contract research organization providing pharmacology services to pharmaceutical and biotech companies.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

preclinical CROcontract research organizationCROin vivo pharmacologyanimal modelsIND enabling studiesoutsourced R&Dnon-human primate studiesNHP studiesPK/PDDMPKGLP toxicologydrug discovery servicesin vitro servicesmedical device testingantibody discoverybiomarker services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PharmaLegacy Comparables

Compare PharmaLegacy with similar companies based on industry and business-model similarity.

PharmaLegacy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beijing Lingfu Biotechnology Co., Ltd.
70%

PharmaLegacy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AJan 13, 2026
Series B ExtensionOct 22, 2021
Series BFeb 1, 2021
Series A ExtensionFeb 2, 2019
Series AFeb 1, 2017

PharmaLegacy Investors

Notable investors and investment history

PharmaLegacy investors
InvestorRounds
CICC CapitalSeries B
Suzhou Guofa Venture CapitalSeries B Extension
HongShan Capital Group (HSG)Series B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 23, 2025

    Monthly visitors grew 621% MoM, reaching 10.1K.

  • Jan 25, 2025

    Monthly visitors grew 67% MoM, reaching 2K.

PharmaLegacy Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PharmaLegacy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PharmaLegacy's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range53
Year Founded2008
Last FundingJan 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.